Xeris Biopharma Holdings, Inc. (XERS)
16.99
+0.19
(+1.13%)
USD |
NASDAQ |
Nov 18, 16:00
17.02
+0.03
(+0.18%)
After-Hours: 20:00
Xeris Biopharma Holdings Price : 16.99 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | 16.93 | 17.28 | 16.72 | 16.99 | 2.763M |
| Nov 17, 2026 | 16.83 | 16.94 | 16.38 | 16.80 | 2.659M |
| Nov 16, 2026 | 16.60 | 16.98 | 16.54 | 16.70 | 2.678M |
| Nov 13, 2026 | 16.60 | 16.76 | 16.31 | 16.66 | 3.399M |
| Nov 12, 2026 | 16.69 | 16.88 | 16.35 | 16.65 | 2.270M |
| Nov 11, 2026 | 15.99 | 16.57 | 15.93 | 16.52 | 3.795M |
| Nov 10, 2026 | 15.75 | 16.11 | 15.22 | 15.83 | 3.779M |
| Nov 09, 2026 | 15.36 | 15.94 | 15.09 | 15.86 | 5.937M |
| Nov 06, 2026 | 13.79 | 15.21 | 13.53 | 15.20 | 7.897M |
| Nov 05, 2026 | 12.51 | 13.74 | 12.32 | 13.08 | 12.60M |
| Nov 04, 2026 | 10.52 | 10.71 | 10.15 | 10.46 | 3.153M |
| Nov 03, 2026 | 10.17 | 10.56 | 10.17 | 10.35 | 3.290M |
| Nov 02, 2026 | 10.71 | 10.72 | 10.08 | 10.17 | 2.309M |
| Oct 30, 2026 | 10.81 | 10.88 | 10.52 | 10.71 | 1.550M |
| Oct 29, 2026 | 10.80 | 10.94 | 10.70 | 10.75 | 1.746M |
| Oct 28, 2026 | 10.45 | 10.75 | 10.39 | 10.64 | 1.452M |
| Oct 27, 2026 | 10.16 | 10.48 | 10.10 | 10.45 | 1.522M |
| Oct 26, 2026 | 10.22 | 10.40 | 10.12 | 10.21 | 1.905M |
| Oct 23, 2026 | 10.85 | 10.85 | 10.06 | 10.20 | 2.372M |
| Oct 22, 2026 | 10.81 | 10.98 | 10.67 | 10.86 | 1.411M |
| Oct 21, 2026 | 11.14 | 11.28 | 10.77 | 10.78 | 1.682M |
| Oct 20, 2026 | 11.00 | 11.35 | 10.96 | 11.13 | 2.901M |
| Oct 19, 2026 | 10.34 | 11.42 | 10.34 | 10.95 | 4.344M |
| Oct 16, 2026 | 10.04 | 10.33 | 9.840 | 10.31 | 2.289M |
| Oct 15, 2026 | 9.77 | 10.18 | 9.76 | 10.07 | 1.942M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ligand Pharmaceuticals, Inc. | 298.71 |
| MBX Biosciences, Inc. | 53.42 |
| ANI Pharmaceuticals, Inc. | 71.47 |
| Corcept Therapeutics, Inc. | 67.79 |
| Veru, Inc. | 2.31 |
Price Related Metrics
| PS Ratio | 8.310 |
| Price to Book Value | 63.58 |
| Price to Free Cash Flow | 42.14 |
| Earnings Yield | -0.27% |
| Market Cap | 3.102B |
| Operating PE Ratio | 65.41 |
| Normalized PE Ratio | 216.99 |